Access
To read this story in full you will need to login or make a payment (see right).
Letters to Nature
Nature 337, 562-566 (9 February 1989) | doi:10.1038/337562a0; Accepted 22 December 1988
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes
David A. Nemazee* & Kurt Bürki†
- *Basel Institute for Immunology, CH-4005 Basel, Switzerland
- †Preclinical Research, Sandoz Ltd, CH-4002 Basel, Switzerland
Abstract
B lymphocytes can be rendered specifically unresponsive to antigen by experimental manipulation in vivo and in vitro1–6, but it remains unclear whether or not natural tolerance involves B-cell tolerance because B cells are controlled by T lymphocytes, and in their absence respond poorly to antigen (reviewed in ref. 7). In addition, autoantibody-producing cells can be found in normal mice and their formation is enhanced by B-cell mitogens such as lipopolysaccharides8–12. We have studied B-cell tolerance in transgenic mice using genes for IgM anti-H–2k MHC class I antibody. In H–2d transgenic mice about 25–50% of the splenic B cells bear membrane immunoglobulin of this specificity, and abundant serum IgM encoded by the transgenes is produced. In contrast, H–2k x H–2d (H–2-d/k) transgenic mice lack B cells bearing the anti-H–2k idiotype and contain no detectable serum anti-H–2k antibody, suggesting that very large numbers of autospecific B cells can be controlled by clonal deletion.
To read this story in full you will need to login or make a payment (see right).
